Dr Rachel Crossland
Professor Anne Dickinson
| A genome-wide association study on hematopoietic stem cell transplantation reveals novel genomic loci associated with transplant outcomes | 2024 |
|
Dr Rachel Crossland
Jamie Macdonald
Dr Xiao Wang
| Assessing MicroRNA Profiles from Low Concentration Extracellular Vesicle RNA Utilizing NanoString nCounter Technology | 2024 |
|
Dr Rachel Crossland
| Donor genetic determinant of thymopoiesis, rs2204985, and stem cell transplantation outcome in a multipopulation cohort | 2024 |
|
Annachiara Scalzone
Dr Rolando Berlinguer Palmini
Professor Anne Dickinson
Dr Xiao Wang
Dr Rachel Crossland
et al. | Functional and Molecular Analysis of Human Osteoarthritic Chondrocytes Treated with Bone Marrow-Derived MSC-EVs | 2024 |
|
Moyassar Al-Shaibani
Dr Xiao Wang
Dr Asif Tulah
Dr Rachel Crossland
Professor Anne Dickinson
et al. | Role of mesenchymal stem cell conditioned medium on wound healing using a developed 3D skin model | 2024 |
|
Kimberly Schell
Steve Bolton
Dr Rachel Crossland
| Complex interactions of cellular players in chronic Graft-versus-Host Disease | 2023 |
|
Dr Aisling Flinn
Kimberly Schell
Professor Andrew Gennery
Dr Rachel Crossland
| Extracorporeal photopheresis as an immunomodulatory treatment modality for chronic GvHD and the importance of emerging biomarkers | 2023 |
|
Dr Rachel Crossland
Professor Anne Dickinson
| Cell-based therapy in prophylaxis and treatment of chronic graft-versus-host disease | 2022 |
|
Dr Alex Newman
Dr Masood Zaka
Dr Peixun Zhou
Dr Alex Blain
Dr Amy Erhorn
et al. | Genomic abnormalities of TP53 define distinct risk groups of paediatric B-cell non-Hodgkin lymphoma | 2022 |
|
Dr Clara Sanjurjo Rodriguez
Dr Rachel Crossland
Dr Xiao Wang
| Characterization and miRNA Profiling of Extracellular Vesicles from Human Osteoarthritic Subchondral Bone Multipotential Stromal Cells (MSCs) | 2021 |
|
Dr Rachel Crossland
Professor Anne Dickinson
| Exploring the Extracellular Vesicle MicroRNA Expression Repertoire in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis Treated with TNF Inhibitors | 2021 |
|
Dr Rachel Crossland
Jean Norden
Dr Kim Pearce
Dr Clare Lendrem
Professor Matthew Collin
et al. | Profiling Tissue and Biofluid miR-155-5p,miR-155* and miR-146a-5p Expression in Graft vs Host Disease | 2021 |
|
Dr Rachel Crossland
Professor Anne Dickinson
| Potential Novel Biomarkers in Chronic Graft-Versus-Host Disease | 2020 |
|
Dr Rachel Crossland
Dr Francesca Perutelli
| Review of Genetic Variation as a Predictive Biomarker for Chronic Graft-Versus-Host-Disease After Allogeneic Stem Cell Transplantation | 2020 |
|
Alex Newman
Dr Masood Zaka
Dr Peixun Zhou
Dr Amy Erhorn
Amy Barnard
et al. | Biallelic Inactivation of TP53 is Associated with an Increased Risk of Relapse in Paediatric B-Cell Non-Hodgkin Lymphoma(B-NHL) | 2019 |
|
Dr Peixun Zhou
Dr Amir Enshaei
Alex Newman
Dr Amy Erhorn
Amy Barnard
et al. | A genomic classification model enables risk stratification of paediatric endemic Burkitt lymphoma | 2018 |
|
Dr Peixun Zhou
Dr Amir Enshaei
Alex Newman
Dr Amy Erhorn
Amy Barnard
et al. | A Genomic Classification Model Enables Risk Stratification of Paediatric Endemic Burkitt Lymphona in Malawi | 2018 |
|
Dr Fahad Ahmed
Dr Sherin Bakhashab
INDA Bastaman
Dr Rachel Crossland
Dr Michael Glanville
et al. | Anti-Angiogenic miR-222, miR-195, and miR-21a Plasma Levels in T1DM Are Improved by Metformin Therapy, Thus Elucidating Its Cardioprotective Effect: The MERIT Study | 2018 |
|
Alex Newman
Dr Masood Zaka
Dr Peixun Zhou
Dr Amy Erhorn
Dr Rachel Crossland
et al. | Biallelic inactivation of TP53 is associated with an increased risk of relapse in paediatric B-cell non-Hodgkin lymphoma (B-NHL) | 2018 |
|
Sadaf Atarod
Jean Norden
Louis Bibby
Dr Clare Lendrem
Dr Kim Pearce
et al. | Differential MicroRNA Expression Levels in Cutaneous Acute Graft-versus-Host Disease | 2018 |
|
Dr Masood Zaka
Dr Rachel Crossland
Amy Barnard
Sara Wilkinson
Dr Simon Bomken
et al. | Integrated analysis of the genomic and microRNA landscapes identifies dysregulated pathways associated with relapsed paediatric B-cell Non-Hodgkin lymphoma | 2018 |
|
Dr Rachel Crossland
Professor Anne Dickinson
| B-Cell-Based and Soluble Biomarkers in Body Liquids for Predicting Acute/Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation | 2017 |
|
Dr Rachel Crossland
Jean Norden
Dr Kile Green
Dr Kim Pearce
Dr Clare Lendrem
et al. | Expression of Serum microRNAs is Altered During Acute Graft-versus-Host Disease | 2017 |
|
Rihab Gam
Pranali Shah
Dr Rachel Crossland
Jean Norden
Professor Anne Dickinson
et al. | Genetic Association of Hematopoietic Stem Cell Transplantation Outcome beyond Histocompatibility Genes | 2017 |
|
Dr Richard Noble
Dr Natalie Bell
Dr Helen Blair
Huw Thomas
Nicole Phillips
et al. | Inhibition of monocarboxyate transporter 1 by AZD3965 as a novel therapeutic approach for diffuse large B-cell lymphoma and burkitt lymphoma | 2017 |
|
Dr Rachel Crossland
Jean Norden
Dr Kim Pearce
Dr Clare Lendrem
Louis Bibby
et al. | Serum and Extracellular Vesicle MicroRNAs miR-423, miR-199, and miR-93* As Biomarkers for Acute Graft-versus-Host Disease | 2017 |
|
Dr Rachel Crossland
Jean Norden
Louis Bibby
Professor Anne Dickinson
| Evaluation of optimal extracellular vesicle small RNA isolation and qRT-PCR normalisation for serum and urine | 2016 |
|
Dr Rachel Crossland
Jean Norden
Professor Anne Dickinson
| Tissue-specific expression Patterns of Microrna during acute graft-versus-host Disease in the rat | 2016 |
|
Gladys -
Dr Kim Pearce
Jean Norden
Dr Clare Lendrem
Dr Rachel Crossland
et al. | Differential microRNA expressions in cutaneous acute graft-versus-host disease | 2015 |
|
Dr Rachel Crossland
Dr Kile Green
Dr Christopher Bacon
Dr Vikki Rand
| Direct digital profiling of multiplexed mRNA expression from degraded formalin fixed paraffin embedded aggressive paediatric B-cell lymphoma tumour tissue | 2015 |
|
Dr Peixun Zhou
Dr Rachel Crossland
Dr Amy Erhorn
Dr Vikki Rand
| High-resolution copy number analysis using low input, degraded DNA from fine-needle aspirates and macrodissected archival Burkitt lymphoma material | 2015 |
|
Dr Peixun Zhou
Dr Rachel Crossland
Dr Amy Erhorn
Dr Vikki Rand
| High-resolution copy number analysis using low input, degraded DNA from fine-needle aspirates and macrodissected archival Burkitt lymphoma material | 2015 |
|
Rihab Gam
Jean Norden
Dr Rachel Crossland
Dr Kim Pearce
Professor Anne Dickinson
et al. | IRAK1 and miR-146a for predicting the outcome of allogeneic haematopoietic stem cell transplantation | 2015 |
|
Rihab Gam
Jean Norden
Dr Rachel Crossland
Dr Kim Pearce
Professor Anne Dickinson
et al. | IRAK1 and miR-146a for predicting the outcome of allogeneic haematopoietic stem cell transplantation | 2015 |
|
Rihab Gam
Jean Norden
Dr Rachel Crossland
Dr Kim Pearce
Professor Anne Dickinson
et al. | MICA genotype, serum and expression level effects on the outcome of HSCT | 2015 |
|
Rihab Gam
Jean Norden
Dr Rachel Crossland
Dr Kim Pearce
Professor Anne Dickinson
et al. | MICA genotype, serum and expression level effects on the outcome of HSCT | 2015 |
|
Dr Christopher Carey
Dr Rachel Crossland
Dr Christopher Bacon
Dr Vikki Rand
| Molecular Classification of MYC-Driven B-Cell Lymphomas by Targeted Gene Expression Profiling of Fixed Biopsy Specimens | 2015 |
|
Dr Rachel Crossland
Jean Norden
Louis Bibby
Professor Matthew Collin
Professor Anne Dickinson
et al. | Serum MicroRNAs MiR-146a, MiR-199, MiR-93*and MiR-423 as Biomarkers for Graft Versus Host Disease | 2015 |
|
Dr Rachel Crossland
Jean Norden
Professor Matthew Collin
Professor Anne Dickinson
| Urinary MicroRNA Expression is Associated with Incidence and Severity of Graft Versus Host Disease | 2015 |
|
Dr Rachel Crossland
Dr Tryfonia Mainou-Fowler
Dr Michal Sieniawski
Dr Christopher Bacon
Dr Vikki Rand
et al. | High BACH2 gene Expression Is an Indicator of Poor Prognosis in Adult Diffuse Large B-Cell Lymphoma Treated with R-CHOP | 2014 |
|
Dr Vikki Rand
Stephen Johnstone
Dr Rachel Crossland
Sarah Wilkinson
Dr Andrew Hall
et al. | The Genomic Landscape of Relapsed B-Cell Acute Lymphoblastic Leukaemia (B-ALL) in Adolescents and Adults | 2014 |
|
Dr Rachel Crossland
Jean Norden
Professor Matthew Collin
Professor Anne Dickinson
| Urinary Micrornas MiR-377, MiR-423, MiR-93 and MiR-199 As Biomarkers for Graft Versus Host Disease | 2014 |
|
Dr Rachel Crossland
Jean Norden
Louis Bibby
Joanna Davis
Professor Anne Dickinson
et al. | Validation of Isolation Methodology and Endogenous Control Selection for qRT-PCR Assessment of Microrna Expression in Serum and Urine Exosomes | 2014 |
|
Dr Rachel Crossland
Dr Michal Sieniawski
Parimala Saminathan
Dr Tryfonia Mainou-Fowler
| MicroRNAs are suitable for assessment as biomarkers from formalin-fixed paraffin-embedded tissue, and miR-24 represents an appropriate reference microRNA for diffuse large B-cell lymphoma studies | 2013 |
|
Dr Rachel Crossland
Dr Michal Sieniawski
Dr Brian Angus
Professor Stephen Proctor
Dr Paul Milne
et al. | Prognostic significance of immunohistochemistry-based markers and algorithms in immunochemotherapy-treated diffuse large B-cell lymphoma patients | 2013 |
|
Dr Rachel Crossland
| The automated monocyte count is independently predictive of overall survival from diagnosis in chronic lymphocytic leukemia and of survival following first-line chemotherapy | 2013 |
|
Dr Rachel Crossland
Dr Michal Sieniawski
Dr Brian Angus
Dr Susan Proctor
Kate McCabe
et al. | Mature microRNAs of the miR-17-92 cluster predict for disease outcome in diffuse large B-cell lymphoma (DLBCL) patients treated with CHOP-R immunochemotherapy | 2011 |
|
Dr Rachel Crossland
Dr Kim Pearce
Dr Nicola Sunter
Dr Tryfonia Mainou-Fowler
| MicroRNAs in B-cell chronic lymphocytic leukaemia (B-CLL): mature microRNAs of the miR-17-92 cluster predict for treatment free survival (TFS) in patients with B-CLL | 2011 |
|
Dr Rachel Crossland
Professor Stephen Proctor
Dr Brian Angus
Dr Stephen Crosier
Dr John Anderson
et al. | A 9 series microRNA signature differentiates between germinal centre and activated B-cell-like diffuse large B-cell lymphoma cell lines | 2010 |
|
Dr Rachel Crossland
Dr John Anderson
Dr Brian Angus
Professor Stephen Proctor
Dr Stephen Crosier
et al. | A 9 series microRNA signature differentiates between germinal centre and activated B-cell-like diffuse large B-cell lymphoma cell lines | 2010 |
|
Dr Rachel Crossland
Dr John Anderson
Dr Brian Angus
Professor Stephen Proctor
Dr Stephen Crosier
et al. | A 9 series microRNA signature differentiates between germinal centre and activated B-cell-like diffuse large B-cell lymphoma cell lines | 2010 |
|
Dr Rachel Crossland
Professor Stephen Proctor
Professor James Allan
| Mature MicroRNAs Mir 18, 19a, 19b, 17 5p and 92 of the Mir 17 92 Cluster Predict for Treatment Free Survival In Patients with Chronic Lymphocytic Leukaemia | 2010 |
|
Dr Rachel Crossland
Professor Stephen Proctor
Professor James Allan
Dr Tryfonia Mainou-Fowler
| Mature MicroRNAs Mir-18,-19a,-19b,-17-5p and-92 of the Mir-17-92 Cluster Predict for Treatment Free Survival In Patients with Chronic Lymphocytic Leukaemia | 2010 |
|
Dr John Anderson
Lynne Overman
Dr Katrina Wood
Professor Stephen Proctor
Dr Stephen Crosier
et al. | Immunophenotyping of diffuse large B-cell lymphoma (DLBCL) defines multiple sub-groups of germinal centre-like tumours displaying different survival characteristics | 2009 |
|
Dr Rachel Crossland
Dr Christine Challen
Dr Bridget Wilkins
Dr Stephen Crosier
Dr John Anderson
et al. | Definitive identification of the Val617Phe mutation in myeloproliferative disorders using Real Time PCR utilising Roche Lightcycler/hybriprobe technology | 2007 |
|
